People living in Australia’s regional areas access cardiovascular disease (CVD) medicines at higher rates than people in major cities or remote areas The report looks at the supply of medicines through the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme (PBS/RPBS) to different Australian regions. The report also shows a different pattern in the case...

Ovarian cancer was the most common cause of gynaecological cancer death and the sixth most common cause of cancer-related death among women in 2006. Although the prognosis for women diagnosed with ovarian cancer was relatively poor compared with a number of other cancers, the prognosis has improved over time. These and other data in this...

This report provides information on what medicines Australians are using to manage their musculoskeletal problems, how much these medicines cost them and trends in the prescription of newer medicines. Medicines are central to managing arthritis and osteoporosis, to improve musculoskeletal functions, slow disease progression and reduce pain and inflammation. Pharmaceutical innovations over the last several...

This paper outlines a range of issues as part of the consultation process for the current review of diagnostic imaging services.

Cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD) account for around a quarter of the burden of disease in Australia, and just under two-thirds of all deaths. These three diseases often occur together and share risk factors, such as physical inactivity, overweight and obesity, and high blood pressure. This report includes information on the...